Dr Andrew Furness
Consultant Medical Oncologist and Solid Tumour Cellular therapy Lead BSc (Hons.) MBBS MRCP PhD
Specialism: Skin, Urology
Available at: Chelsea, Sutton
- Kidney cancer
- Novel immunotherapeutic approaches including adoptive cell-based and biological therapeutics
Dr Andrew Furness is a Consultant Medical Oncologist specialising in the treatment of cancers of the kidney and skin.
Dr Furness completed his undergraduate medical training at Guy’s, King’s and St Thomas’ School of Medicine, London; where he also undertook an intercalated BSc in Human Physiology.
Following completion of core training in internal medicine, he undertook specialist training in Medical Oncology at The Royal Marsden under the mentorship of Professor Martin Gore.
In 2013, he was awarded the Sam Keen Foundation Fellowship and spent four years studying Cancer Immunology at University College London Cancer Institute. During this time he studied the immune landscape of human tumours and made fundamental contributions to current understanding of the mechanisms underlying the activity of immune-modulatory antibody-based therapies; he was awarded a PhD in 2018.
His findings have been published in high impact journals including Cancer Cell, Immunity and Science and his efforts have been recognised with a number of awards including the Association of Cancer Physicians McElwain Prize and Cancer Research UK Translational Research Prize.
In 2019, he was appointed as a Consultant in Medical Oncology and Solid Tumour Cell Therapy lead. He is currently a faculty member of the ESMO Tumour Immunology and Immunotherapy group and sits on the ESMO Precision Medicine and Translational research working group.
His research interests are centred in translational immunology and the clinical application of cell therapy for solid tumours.